AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04959942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: scapular stabilization exercise
Description: In the supine position, the subject will instruct to take a deep breath to relax the body. In croock-lying position, the subject will raise his dominant arm to 90° shoulder flexion with full elbow extension and scapular protraction. In the quadruped position, the subject lifts up his arms alternatively with shoulder abduction and 120 ° flexion. In a sitting position with 90° knee flexion on a stool or bed without back support, the subject held a pair of dumbbells (2 kg) in each hand and laterally lifted them up while maintaining the height of scapulae below 80°. Each stage will instruct to be held for 10 seconds before returning to the starting position and three laps of 10 repetitions with a 30-second break in between will perform. In the sitting position, a mirror will place in front of the patient. The subject will instruct to check and correct his posture by him
Study NCT04959942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scapular stabilization exercise
Description: In the supine position, the subject will instruct to take a deep breath to relax the body. In croock-lying position, the subject will raise his dominant arm to 90° shoulder flexion with full elbow extension and scapular protraction. In the quadruped position, the subject lifts up his arms alternatively with shoulder abduction and 120 ° flexion. In a sitting position with 90° knee flexion on a stool or bed without back support, the subject held a pair of dumbbells (2 kg) in each hand and laterally lifted them up while maintaining the height of scapulae below 80°. Each stage will instruct to be held for 10 seconds before returning to the starting position and three laps of 10 repetitions with a 30-second break in between will perform. In the sitting position, a mirror will place in front of the patient. The subject will instruct to check and correct his posture by him
Study NCT06268327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin injection and gemcitabine
Description: Patients with operable, primary invasive noninflammatory early TNBC of stage I-IIIB and pathologically verified residual cancer cells (no pathological complete response) after neoadjuvant chemotherapy then underwent adjuvant treatment with gemcitabine plus cisplatin Pt will be followed up every 3 month in first year then every 6 month in the second year then followed up yearly Study will be conducted at Assiut University Hospital with sample size calculation BRACA will be done
Study NCT06268327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine tablets
Description: Patients with operable, primary invasive noninflammatory early TNBC of stage I-IIIB and pathologically verified residual cancer cells (no pathological complete response) after neoadjuvant chemotherapy then underwent adjuvant treatment with capecitabine Pt will be followed up every 3 month in first year then every 6 month in the second year then followed up yearly Study will be conducted at Assiut University Hospital with sample size calculation BRACA will be done
Study NCT06010381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscle energy technique
Description: It was applied on the shoulder flexion and the external rotation. An isometric contraction of the agonist muscle (the muscle which requires stretching) for 7 seconds with gentle muscle contraction to avoid the risk of increasing the muscle tone. This contraction started just short of the restrictive barrier. After that, the patient is asked to relax for 2-3 seconds and then the therapist stretches the contracted muscle in the opposite direction for 30 seconds. This is repeated three repetitions for each muscle.
Study NCT06010381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Maitland mobilization
Description: At the start of each session, the physical therapist examined the patient's ROM in all directions to obtain information about the end-range position and the end feel of the glenohumeral joint. Start with rhythmic mid-range mobilization with the patient in a supine position. The therapist's hands are placed close to the glenohumeral joint, and the humerus is brought into a position of maximal flexion in the sagittal plane. After 10 to 15 repetitions of intensive mobilization techniques in this end-range position, the direction of mobilization will be altered by varying the plane of elevation or by varying the degree of rotation. When alternating the direction of mobilization, other movements such as gliding techniques and distraction in that joint position were (inferior gliding, anterior gliding, and posterior gliding).
Study NCT06010381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional shoulder exercise
Description: Traditional shoulder exercises in the form of shoulder range of motion exercises, stretching exercises and, scapular stabilization.
Study NCT05120375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAT6021
Description: Ⅳ infusions
Study NCT04959942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural correction exercise
Description: The program consisted of two strengthening (deep cervical flexors and scapular retractors) and two stretchings: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall.
Study NCT04959942 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural correction exercise
Description: The program consisted of two strengthening (deep cervical flexors and scapular retractors) and two stretchings: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall.
Study NCT04959942 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: advice
Description: all subjects will be instructed to maintain normal alignment of the cervical vertebry
Study NCT06292026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ProgenaMatrix Keratin graft
Description: place ProgenaMatrix graft on the wound
Study NCT06292026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard of care
Description: apply non adherent dressing
Study NCT05290935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 antibody camrelizumab
Description: Camrelizumab: 200 mg every time, every 3 weeks, which would be sustained until the appearance of disease progression on intolerable adverse events, and no more than 24 months
Study NCT05290935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel
Description: Albumin-bound paclitaxel: 200-300 mg every time, every 3 weeks, no more than 6 courses
Study NCT05110560 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stay at Home Take a Step Program (SHTSP)
Description: The Stay at Home Take a Step Program consisting of video or audio calls four times, sending Short Message Service messages containing reminders to encourage walking, and daily step count and weight tracking will be implemented.
Study NCT05139381 — intervention group
Intervention type: DRUG
Intervention: Mepolizumab
Description: Treatment with Mepoluzimab
Study NCT05664295 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Jenkins Sleep Disorders scale and Epworth Sleepiness scale
Description: Jenkins Sleep Disorders scale and Epworth Sleepiness scale
Study NCT06423807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron lozenge
Description: Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.
Study NCT05493488 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DBI-001 Gel
Description: Topical application of DBI-001 gel on foot/feet affected with tinea pedis
Study NCT05493488 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: DBI-002 Gel
Description: Topical application of DBI-002 gel on foot/feet affected with tinea pedis
Study NCT05493488 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Aqueous Gel
Description: Topical application of Aqueous gel on foot/feet affected with tinea pedis
Study NCT05667038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: The probiotics sachet contains a granular powder with 6 microorganism strains (30 × 109 CFU/gram): Lactobacillus acidophilus BCMC®12130, Lactobacillus casei subsp BCMC®12313, Lactobacillus lactis BCMC®12451, Bifidobacterium bifidum BCMC®02290, Bifidobacterium infantis BCMC®02129, and Bifidobacterium longum BCMC®02120.~The drug is consumed orally, two sachets per day, by dissolving the sachet content in a glass of room-temperature water, one before breakfast and one before the last meal, for three months length.
Study NCT05667038 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo:~Subjects in the placebo group will receive the placebo consisting of only the carrier of the probiotic product, that is maize starch and maltodextrins.~The sachet is consumed orally, two sachets per day, by dissolving the sachet content in a glass of room-temperature water, one before breakfast and one before the last meal, for three months length.
Study NCT06226441 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Renal Replacement Therapy
Description: CRRT
Study NCT05413993 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: photobiomodulation
Description: Laser application intraorals and extraoral points in the region of the salivary glands bilaterally
Study NCT05413993 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: photobiomodulation
Description: Laser application intraorals and extraoral points in the region of the salivary glands bilaterally
Study NCT06196853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aminophylline
Description: Give aminophylline for 5 days to keep serum theophylline level 5-15 mg/dl
Study NCT06464302 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical stabilisation of rib fractures (SSRF)
Description: Surgical stabilisation of rib fractures using any fixation technique (including but not limited to plate fixation, intramedullary fixation, wire fixation) via any operative approach (including but not limited to open external approach, minimally invasive approach, thoracoscopic approach, thoracotomy approach).
Study NCT06464302 — intervention group
Intervention type: OTHER
Intervention: Non-operative management of rib fractures
Description: Any supportive or specific treatment of rib fractures excluding surgical stabilisation of rib fractures. This includes, but is not limited to analgesia, physiotherapy, non-invasive ventilation, mechanical ventilation, oxygen-supplementation
Study NCT05959252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Unfractionated heparin
Description: Unfractionated Heparin protocol with target anti-Xa of 0.3-0.5 IU/mL
Study NCT05051826 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training that combines water and land
Description: Device: Swimmers in the experimental group received resistance training in water for 12 weeks, and the resistance training in the experimental group was divided into 3 categories:Resistance palm and resistance umbrella, resistance suit.~Device: The swimmers in the experimental group underwent core strength training on land for 12 weeks, and the resistance training in the experimental group was divided into 4 types of resistance zones: Swiss ball, medicine ball and drive zone.The combination of two resistance training methods can improve teenagers' swimming performance.
Study NCT06326749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Graded Motor Imagery and Conventional Treatment Group
Description: A modified form of graded motor imagery training and conventional rehabilitation will be applied.
Study NCT06326749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graded Motor Imagery and Conventional Treatment Group
Description: Graded motor imagery training and conventional rehabilitation will be applied.
Study NCT06326749 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Treatment Group
Description: conventional rehabilitation will be applied.
Study NCT06294938 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cacao fruit pulp
Description: Cacao pulp puree
Study NCT06294938 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dextrose
Description: Dextrose beverage
Study NCT06508307 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors
Description: The maximum number of lesions that each participant is allowed to inject at one time is two.
Study NCT05324020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication adherence eHealth intervention
Description: The eHealth intervention consists a Medication Event Monitoring Systems (MEMS®) Helping Hand and MEMS Adherence Software application. The eHealth intervention will support BCS to adhere to their OHT (i) by alerting them to take their OHT, and (ii) by allowing patient-physician communication.~The eHealth intervention comprises a questionnaire that should be filled-out weekly and that informs about the presence and severity of side effects. These data are collected in real-time and monitored on a weekly basis by the clinical research nurse (CRN) in charge of the study. In case of an alert, meaning recurrent non-adherence and/or reporting of side-effects, the CRN will contact the breast cancer nurse (BCN) in charge of the patient. Thus the BCN will contact the patient by phone to check on their health status and together define the future procedures (behavioral strategies).
Study NCT05482633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Description: Treatment group will perform IMT every day for eight weeks. Initial load is going to be set as the 60% of maximal inspiratory pressure (PImax) and is going to be increased by %10 of the initial load every two weeks.
Study NCT04998344 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Description: Vaccines will be administered as a single dose regimen for the pregnant women and two doses for children at 28-day interval as recommended by the vaccine manufacturers.
Study NCT04998344 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Inactivated polio vaccine
Description: Vaccines will be administered as a single dose regimen for the pregnant women and two doses for children at 28-day interval as recommended by the vaccine manufacturers.
Study NCT04905563 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Acetaminophen-Hydrocodone
Description: Narcotic
Study NCT04905563 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen and Ibuprofen
Description: Non-narcotic
Study NCT05959252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bivalirudin
Description: Bivalirudin protocol with target aPTT 50-70 seconds
Study NCT05470205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHAPE measurement (Sonazoid ultrasoud contrast agent)
Description: Three vials with 48 µl of Sonazoid (GE Healthcare, Oslo, Norway) microbubbles (6 ml) will be prepared and drawn into a 10 ml syringe, placed in a syringe pump. Sonazoid will be co-infused at a rate of 0.024 µl/kg body weight/minute (suspension infusion rate of 0.18 ml/kg/hour) together with a 0.9% NaCl solution infused at a rate of at least 2 ml/min.
Study NCT05470205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHAPE measurement (Definity ultrasoud contrast agent)
Description: Two vials with 3 mL of Definity will be mixed and diluted in 50 mL of normal saline, yielding a concentration of 49.4 μL/mL, and infused at a rate of at least 4 ml/min.
Study NCT01101347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aneurysm-Embolization System
Study NCT05058248 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pudendal block
Description: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco
Study NCT05058248 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: pudendal block
Description: general anesthesia with an intravenous analgesic protocol then oral without anesthesia regional loco
Study NCT06522685 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT
Description: Soterix Medical REMOTE Neuromodulation is the only system with device, accessories, and software designed for deployed use. Safe transcranial Electrical Stimulation requires advanced systems designed for consistency and control. REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.
Study NCT06522685 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT
Description: Soterix Medical REMOTE Neuromodulation is the only system with device, accessories, and software designed for deployed use. Safe transcranial Electrical Stimulation requires advanced systems designed for consistency and control. REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.
Study NCT05868733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Day 1 Lower Dose (2×106 pfu)
Description: rVSV∆G-LASV-GPC
Study NCT04663828 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Structured counseling
Description: Structured patient education and counselling is considered as providing information to patients in order to empower them to better manage their disorder
Study NCT04663828 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Hearing aids
Description: Hearing aids are considered medical devices and are recommended to patients with a certain degree of hearing loss. Hearing aids amplify environmental sounds.
Study NCT04663828 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cognitive behavioral therapy
Description: This is a structured intervention and consists of a several week program both with noise exposure and structured interviews and expert-patient as well as patient-patient interaction in groups
Study NCT05868733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Day 1 Higher Dose (1×107 pfu)
Description: rVSV∆G-LASV-GPC
Study NCT04663828 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sound therapy
Description: Several sounds and music are used for tinnitus disorder
Study NCT05868733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT06055491 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D3 or Saline injection at ipsilateral deltoid muscle
Description: study group: 1.0mL Vitamin D3 injection control group: 1.0mL saline injection
Study NCT06055491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D3 or Saline injection at ipsilateral deltoid muscle
Description: study group: 1.0mL Vitamin D3 injection control group: 1.0mL saline injection
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3871801
Description: Administered orally.
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Administered orally.
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Description: Administered orally.
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Description: Administered orally.
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Administered orally.
Study NCT05602675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Repaglinide
Description: Administered orally.
Study NCT05616819 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active light exposure
Description: Active light at the wave length of 470nm will be emitted for 30 minutes over a 2 week time frame, from commercially available ayo glasses, as a method to regulated circadian rhythm.
Study NCT05616819 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo light exposure
Description: Placebo light at the wave length of 578nm will be emitted for 30 minutes over a 2 week time frame, from commercially available ayo glasses, as a control to investigate the regulation of circadian rhythm.
Study NCT05403892 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: level laser lunge test
Description: In order to perform the Level Laser Test, the operator 1 places a laser lever on the ground one metre aside and 50 cm forward the ankle to be examined. This laser (a 2-class laser not harmful to the eyes) maintains a linear laser light beam perpendicular to the floor. The examined leg is placed further forward to the other one, as it happens in the DLT. The teenage performs a forward lunge perpendicularly to the laser line, the heel positioning 50 cm from the laser line. Operator 1 has the subject perform a lunge while operator 2 measures the distance from the kneecap to the laser line. The measurement, deducted by 50 cm, leads to the heel-to-wall distance (value used to DLT).
Study NCT05403892 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: dorsiflexion Lunge test
Description: The dorsiflexion lunge test (DLT) will be used to measure ankle dorsiflexion. To perform this test, the teenage stands in front of a wall holding the foot of their limb to be measured perpendicularly to it. The other foot is to be kept behind it. The teenage is asked to perform a lunge (to dorsiflex the ankle and bring the knee into flexion) until the front knee touches the wall without the heel lifting off the ground. The teenage steps away from the wall as much as possible as long as the knee keeps touching the wall. Measurement in centimeters is taken from the heel of the examined leg to the wall.